Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 938-419-4 | CAS number: 3904-24-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 26, 2013 - April 15, 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- 2003
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- (2R)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride
- Cas Number:
- 93601-85-5
- Molecular formula:
- C14H21NO.HCl
- IUPAC Name:
- (2R)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride
- Reference substance name:
- (2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride (1:1)
- EC Number:
- 695-797-0
- Cas Number:
- 93601-86-6
- Molecular formula:
- C14H21NO.HCl
- IUPAC Name:
- (2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride (1:1)
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Appearance: Mauve powder
- Storage condition of test material: At room temperature in the dark
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/J
- Sex:
- female
- Details on test animals and environmental conditions:
- - Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: Young adult animals
(main study: approx. 9 weeks old; range finding tests: approx. 10-12 weeks old)
- Weight at study initiation:
Main study: 19-23 g; range finding tests: 22-26 g
- Housing: Animals were group housed in labeled Makrolon cages
- Diet: Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany).
- Water: Free access to tap water
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS (set conditions)
- Temperature (°C): 18 – 24
- Humidity (%): 40 - 70
- Air changes (per hr): approx. 15
- Photoperiod (hrs dark / hrs light): 12/12
Variations to these conditions occurred (i.e. minimum relative humidity of 24 or 33% on a single day, respectively). Based on the laboratory’s extensive experience with variations in these parameters and absence of any clinical signs among the animals that could be associated to these variations, these were considered to have no effect on the outcome of the study.
IN-LIFE DATES: From: March 27, 2013 to April 15, 2013
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- 0, 10, 25, 50%
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS
In a pre-screen test, two test substance concentrations were tested; a 25% and 50% concentration. Two young adult animals per concentration were selected. Each animal was treated with one concentration for three consecutive days. Ear thickness measurements were conducted prior to dosing on Days 1 and 3, and on Day 6. Animals were sacrificed after the final observation.
MAIN STUDY
INTERPRETATION
- Criteria used to consider a positive response: DPM values are presented for each animal and for each dose group. A Stimulation Index (SI) is calculated for each group. The SI is the ratio of the DPM/group compared to DPM/vehicle control group. If the results indicate a SI ≥ 3, the test substance may be regarded as a skin sensitizer.
ANIMAL ASSIGNMENT
Three groups of five animals were treated with one test substance concentration per group. One group of five animals was treated with vehicle.
TREATMENT PREPARATION AND ADMINISTRATION:
- Test substance preparation: The test substance formulations (w/w) were prepared within 4 hours prior to each dosing. No adjustment was made for specific gravity of the vehicle. Homogeneity was obtained to visually acceptable levels by shaking, vortexing and stirring. This resulted in a turbid formulation for the 10 and 25% concentration and in a suspension for the 50% concentration.
- Rationale for vehicle: The vehicle was selected based on trial formulations performed at WIL Research.
Performed according to test guidelines:
- Days 1, 2 and 3: Induction. Topical treatment of 25 µL/ear, using a pipette or spatula (highest concentration)
- Day 6: Injection of 20 µCi 3H-methyl thymidine. Five hours after the injection, all animals were killed and the ear lymph nodes were excised. The relative size of the nodes (as compared to normal) was estimated by visual examination and abnormalities of the nodes and surrounding area were recorded. The nodes were pooled for each animal in approximately 3 mL Phosphate buffered saline (PBS).
- Day 6: Tissue processing for radioactivity. A single cell suspension of lymph node cells was prepared in PBS by gentle separation through stainless steel gauze (diameter 125 μm). The cells were washed twice with an excess of PBS by centrifugation at 200 g for 10 minutes at 4°C. To precipitate the DNA, the cells were exposed to 5% trichloroacetic acid (TCA) and stored in the refrigerator until the next day.
- Day 7: Radioactivity measurements using a Packard scintillation counter (2800TR). Precipitates were recovered by centrifugation, resuspended in 1 mL TCA and transferred to 10 mL of Ultima Gold cocktail (PerkinElmer Life and Analytical Sciences, Boston, US) as the scintillation fluid.
Observations:
Mortality/Viability: Twice daily.
Body weights: On Day 1 (pre-dose) and Day 6 (prior to necropsy).
Clinical signs: Once daily on Days 1-6 (on Days 1-3 between 3 and 4 hours after dosing).
Irritation: Once daily on Days 1-6 (on Days 1 - 3 within 1 hour after dosing) - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The six-month reliability check with Alpha-hexylcinnamicaldehyde indicates that the Local Lymph Node Assay as performed at WIL Research Europe is an appropriate model for testing for contact hypersensitivity.The SI values calculated for the concentrations 5, 10 and 25% were 1.2, 1.6 and 7.7, respectively. An EC3 value of 13.4% was calculated using linear interpolation.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.4
- Test group / Remarks:
- Substance concentration 10%
- Key result
- Parameter:
- SI
- Value:
- 1.1
- Test group / Remarks:
- Substance concentration 25%
- Key result
- Parameter:
- SI
- Value:
- 0.9
- Test group / Remarks:
- Substance concentration 50%
Any other information on results incl. tables
Results Pre-screen test:
No irritation and no signs of systemic toxicity were observed in any of the animals examined. Slight body weight loss was noted among the animals. This was considered not toxicologically significant since the changes were slight in nature and no further clinical signs were noted.
Variations in ear thickness during the observation period were less than 25% from Day 1 pre-dose values. Purple test substance remnants were present on the dorsal surface of the ears of both animals at 25% and 50% (Days 1-3), which did not hamper scoring of the skin reactions.
Based on these results, the highest test substance concentration selected for the main study was a 50% concentration (highest technically possible concentration for a solid).
Other results - main study:
- No irritation of the ears was observed in any of the animals examined. Purple test substance remnants were present on the dorsal surface of the ears of both animals at 10, 25 and 50% (Days 1-3), which did not hamper scoring of the skin reactions.
- The majority of auricular lymph nodes were considered normal in size, except for the nodes in one animal at 50%, which were considered larger in size. This increase in size did not show a relation to the DPM/animal values as a similar DPM value was measured for other animals at lower concentrations without an increase in lymph node size. No macroscopic abnormalities of the surrounding area were noted in any of the animals.
- No mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study.
- Body weights and body weight gain of experimental animals remained in the same range as controls over the study period. The body weight loss noted for some animals (1 to 3 g; at 10 and 25%) was considered not toxicologically significant since the changes were slight in nature and no concentration-related incidence was apparent.
Applicant's summary and conclusion
- Interpretation of results:
- other: the substance does not need to be classified as skin sensitiser according to GHS and CLP
- Conclusions:
- In an LLNA skin sensitisation study, performed according to OECD/EC test guidelines, the substance was considered not be a skin sensitiser, as the SI was shown to be < 3 when tested up to and including 50%.
- Executive summary:
An LLNA skin sensitisation study was performed according to OECD/EC test guidelines with the substance. Reliable positive and negative controls were included. Based on the results of a pre-screen test, three experimental groups of five female CBA/J mice were treated with test substance concentrations of 10, 25 or 50% w/w on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with vehicle alone (dimethylformamide). No irritation of the ears was observed in any of the animals examined. The majority of auricular lymph nodes were considered normal in size, except for the nodes in one animal at 50%, which were considered larger in size. This increase in size did not show a relation to the DPM/animal values as a similar DPM value was measured for other animals at lower concentrations without an increase in lymph node size. No macroscopic abnormalities of the surrounding area were noted in any of the animals.
Mean DPM/animal values for the experimental groups treated with test substance concentrations 10, 25 and 50% were 876, 688 and 568 DPM, respectively. The mean DPM/animal value for the vehicle control group was 625 DPM. The SI values calculated for the substance concentrations 10, 25 and 50% were 1.4, 1.1 and 0.9, respectively. Based on these data, the substance is considered not be a skin sensitiser, as the SI was shown to be < 3 when tested up to and including 50%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.